Redmile Biopharma Investments I, L.P. — Form D
Redmile Biopharma Investments I, L.P. of SAN FRANCISCO, CA, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2015-07-28. The offering totals $150.0M. Industry: Pooled Investment Fund.
Offering
- Filed: 2015-07-28
- Form: D
- Accession: 0001649327-15-000001
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.1, 3C.7
- Total offering: $150.0M
- Remaining: $150.0M
- Security types: fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-244604
Issuer
- Name: Redmile Biopharma Investments I, L.P.
- CIK: 0001649327
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: ONE LETTERMAN DRIVE, BUILDING D, SAN FRANCISCO, CA, 94129
- Phone: 415-489-9980
Officers, directors & promoters (12)
| Name | Role | Location |
|---|
| Jonathan NA Forman | Promoter | San Francisco, CA |
| N/A NA Redmile Biotechnologies Investments I (GP), LLC | Promoter | San Francisco, CA |
| Amrit Nagpal | Promoter | South San Francisco, CA |
| Jeremy Green | Promoter | New York, NY |
| Mike Lee | Promoter | Palo Alto, CA |
| Managing Mbr of the GP of the Issuer Redmile Group, LLC | Promoter | San Francisco, CA |
| General Partner Redmile Biopharma Investments I (GP), LLC | Promoter | San Francisco, CA |
| Mike NA Lee | Promoter | San Francisco, CA |
| N/A NA Redmile Biopharma Investments I (GP), LLC | Promoter | San Francisco, CA |
| N/A NA Redmile Group, LLC | Promoter | San Francisco, CA |
| Jeremy NA Green | Promoter | San Francisco, CA |
| Amrit NA Nagpal | Promoter | San Francisco, CA |
Other filings by this issuer (3)
More